APOE4 non-carriers demonstrated a distinct pattern of reduced striatal intracellular integrity (caudate RI) with cognitive impairment, which may point to AD-independent striatal contributions to clinical symptoms, as various conditions including Parkinson’s disease and psychiatric disorders are accompanied by striatal dysfunction [52, 53]. This evidence concerns the gene APOE and Alzheimer disease.